Ilze Bot
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 124 publications
Corrigendum to immunopeptidomics analysis of human atherosclerosis plaques identifies antigenic drivers of atherosclerosis[Atherosclerosis, (409), October 2025, 120509].
Journal: Atherosclerosis
Published: February 26, 2026
Age-associated B-cells predict coronary events in humans and aggravate murine atherosclerosis.
Journal: Cardiovascular research
Published: December 03, 2025
Modulation of IL-1, IL-6 and IL-18 cytokine signaling in animal models of atherosclerosis: a systematic review evaluating animal sex in preclinical research.
Journal: European journal of pharmacology
Published: September 28, 2025
Mast cells in cardiovascular disease: Fibrosis, angiogenesis and atherogenesis.
Journal: Progress in cardiovascular diseases
Published: September 02, 2025
Myeloid Protein Kinase C Epsilon: A New Marker for Plaque Stability?
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: August 07, 2025
Immunosenescence accelerates atherosclerosis development in AAV-PCSK9 mouse model.
Journal: GeroScience
Published: April 01, 2025
Carotid plaque macrophage burden and inflammatory lipid-associated macrophage markers predict secondary major adverse cardiovascular events after endarterectomy.
Journal: European heart journal
Published: March 03, 2025
In vitro and in vivo lipopolysaccharide-driven activation of human neutrophils in healthy volunteers as a tool for clinical drug development.
Journal: Journal of immunological methods
Published: January 09, 2025
Leukemia inhibitory factor receptor inhibition by EC359 reduces atherosclerotic stenosis grade in Ldlr-/- mice.
Journal: European journal of pharmacology
Published: August 27, 2024
NLRP3 Inflammasome Inhibition by the Novel Bispecific Antibody InflamAb Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
Journal: JACC. Basic to translational science
Published: July 16, 2024
Immunoproteasomal Inhibition With ONX-0914 Attenuates Atherosclerosis and Reduces White Adipose Tissue Mass and Metabolic Syndrome in Mice.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: April 25, 2024
Last Updated: 09/26/2026